202 related articles for article (PubMed ID: 31432422)
1. Untargeted Metabolomics Relative Quantification by SWATH Mass Spectrometry Applied to Cerebrospinal Fluid.
Mendes VM; Coelho M; Manadas B
Methods Mol Biol; 2019; 2044():321-336. PubMed ID: 31432422
[TBL] [Abstract][Full Text] [Related]
2. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
Anjo SI; Santa C; Manadas B
Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
[TBL] [Abstract][Full Text] [Related]
3. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
Ziganshin RH; Kovalchuk SI; Azarkin IV
Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
[TBL] [Abstract][Full Text] [Related]
4. Use of information dependent acquisition mass spectra and sequential window acquisition of all theoretical fragment-ion mass spectra for fruit juices metabolomics and authentication.
Xu L; Xu Z; Strashnov I; Liao X
Metabolomics; 2020 Jul; 16(7):81. PubMed ID: 32638130
[TBL] [Abstract][Full Text] [Related]
5. Co-extraction for Metabolomics and Proteomics from a Single CSF Sample.
Hörmann P; Barkovits K; Marcus K; Hiller K
Methods Mol Biol; 2019; 2044():337-342. PubMed ID: 31432423
[TBL] [Abstract][Full Text] [Related]
6. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
7. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology.
Wang R; Yin Y; Zhu ZJ
Anal Bioanal Chem; 2019 Jul; 411(19):4349-4357. PubMed ID: 30847570
[TBL] [Abstract][Full Text] [Related]
8. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
9. Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications.
Boxler MI; Schneider TD; Kraemer T; Steuer AE
Drug Test Anal; 2019 May; 11(5):678-696. PubMed ID: 30408838
[TBL] [Abstract][Full Text] [Related]
10. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
11. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
12. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using
Birke R; Krause E; Schümann M; Blasig IE; Haseloff RF
Methods Mol Biol; 2019; 2044():119-128. PubMed ID: 31432410
[TBL] [Abstract][Full Text] [Related]
15. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
16. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
[TBL] [Abstract][Full Text] [Related]
17. An integrated strategy to improve data acquisition and metabolite identification by time-staggered ion lists in UHPLC/Q-TOF MS-based metabolomics.
Wang Y; Feng R; He C; Su H; Ma H; Wan JB
J Pharm Biomed Anal; 2018 Aug; 157():171-179. PubMed ID: 29802989
[TBL] [Abstract][Full Text] [Related]
18. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic spectral libraries for data-independent SWATH liquid chromatography mass spectrometry acquisition.
Bruderer T; Varesio E; Hidasi AO; Duchoslav E; Burton L; Bonner R; Hopfgartner G
Anal Bioanal Chem; 2018 Mar; 410(7):1873-1884. PubMed ID: 29411086
[TBL] [Abstract][Full Text] [Related]
20. Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma.
Xiao J; Shi J; Li R; Her L; Wang X; Li J; Sorensen MJ; Bhatt-Mehta V; Zhu HJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122865. PubMed ID: 34365292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
